Health Watch | Alzheimer’s scientists find key to halting brain decline before symptoms

Title: Alzheimer’s scientists find key to halting brain decline before symptoms

Article Snip: "...Scientists may have found a way to stop Alzheimer’s damage before it starts ...“There are already treatments on the market to target beta amyloid buildup, and now here’s a targeted therapy to dissolve and disrupt tau protein buildup before it forms the dreaded neurofibrillatory tangles.” Siegel believes this is “bound to be of clinical value” and will likely be better tolerated than other medications currently on the market."

Reference: nypost.com

---

---

Health Watch | These special traits may shield ‘SuperAgers’ from dementia — how they could lead to new Alzheimer’s tools

Title: These special traits may shield ‘SuperAgers’ from dementia — how they could lead to new Alzheimer’s tools

Article Snip: "...Life expectancy in the US hovers around 78.4 years — there’s a special group of people who surpass this mark with flying colors. The retirees, known as “SuperAgers,” exhibit the memory and cognitive abilities of people in middle age.

A new report out of Northwestern University reveals unique traits of SuperAger brains that appear to shield them from dementia. ..."

Reference: nypost.com
Health Watch, SuperAgers, Dementia,Alzheimer's,

---

---

FDA fully approves 'novel' Alzheimer’s disease drug Leqembi, will be covered by Medicare

Title: FDA fully approves 'novel' Alzheimer’s disease drug Leqembi, will be covered by Medicare

Article Snip: "Leqembi has shown clinical benefit in fighting Alzheimer's disease. ...The Food and Drug Administration (FDA) has fully approved a "novel" drug used to treat adult patients with Alzheimer’s, the agency announced. Leqembi, which is produced by Japanese drugmaker Eisai and American-based drugmaker Biogen..."

Reference: www.foxnews.com
Leqembi,Medicare,Alzheimer's, Health,Alzheimer’s Drugs,Food and Drug Administration (FDA),amyloid beta-directed antibody, Biogen, Eisai, Lecanemab,

---

---